Unlisted holdings
% of total assets |
---|
N/R |
Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 30/06/2022
Investment | % of total assets |
---|---|
ImmunoBiology Limited | 25.1 |
OR Productivity Limited | 22.1 |
Scancell Holdings Plc | 19.2 |
Insense Limited | 14.7 |
Fuel 3D Technologies Limited | 8.6 |
Arecor Therapeutics Plc | 6.6 |
Microarray Limited | 3.8 |
Industry breakdown
Data as at : 30/06/2022
Industry | % of total assets |
---|---|
Healthcare | 87.4 |
Cash Equivalents | 3.6 |
Asset breakdown
Data as at : 30/06/2022
Asset | % of total assets |
---|---|
Stock | 87.4 |
Other | 8.9 |
Cash/Cash equivalents | 3.6 |
Detailed asset breakdown
Data as at : 30/06/2022
Asset | % of total assets |
---|---|
UK - Small core/growth stock | 57.8 |
Other - stock | 29.6 |
Other | 8.9 |
Cash | 3.6 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.